Seven neurokinin (NK) receptor inhibitors SCH 60059 (1), SCH 60065 (2), SCH 64879 (3), SCH 60061 (4), SCH 60063 (5), SCH 60057 (7), and SCH 64878 (9) and two uncharacterized components 6 and 8, were isolated from the fermentation broth of a fungus taxonomically classified as an Acremoniumsp. These compoundswere isolated from the fermentation broth by ethyl acetate extraction. Purification and separation of the individual compoundswere achieved by NKXand NK2assay-guided fractionation using gel filtration, reverse phase chromatography and HPLC.The NK active compounds were identified to be a family of polyhydroxy isoprenoid derivatives, including glycosylated members, by spectroscopic and degradation studies. Compounds 1~5 and 7 contain nine isoprene units connected in head to tail fashion and compound9 contains fifteen isoprene units connected in a similar manner. All these compoundsshoweddual inhibition in NKXand NK2assays with IC50 values ranging from 2.5~ll [iu in the NKXassay and 6.8~16//m in the NK2assay.
components 6 and 8, were isolated from the fermentation broth of a fungus taxonomically classified as an Acremoniumsp. These compoundswere isolated from the fermentation broth by ethyl acetate extraction. Purification and separation of the individual compoundswere achieved by NKXand NK2assay-guided fractionation using gel filtration, reverse phase chromatography and HPLC.The NK active compounds were identified to be a family of polyhydroxy isoprenoid derivatives, including glycosylated members, by spectroscopic and degradation studies. Compounds 1~5 and 7 contain nine isoprene units connected in head to tail fashion and compound9 contains fifteen isoprene units connected in a similar manner. All these compoundsshoweddual inhibition in NKXand NK2assays with IC50 values ranging from 2.5~ll [iu in the NKXassay and 6.8~16//m in the NK2assay.
Neurokinins (NK) are a family of 9 to ll amino acid peptides with a commonC-terminal sequence (Phe-XGly-Leu-Met-NH2) which trigger a variety of inflammatory responses.1>2)
The most well characterized neurokinins namely substance P, NKAand NKBare involved in a variety of responses including pain transmission, neurogenic inflammation, bronchoconstriction and vasodilation. These peptides act principally through 7 /raws-membrane domain G protein-coupled receptors that have been cloned and are termed NK1? NK2 and NK3and have selective affinity for substance P, NKA and NKBrespectively.3) A numberof non-peptide neurokinin antagonists have been identified and these have been useful in clarifying the pathophysiologic roles of neurokinins in a variety of diseases including asthma.4) In particular, NKXselective antagonists such as CP-99994 and CP-96345 blocked several features of pulmonary inflammation namely vasodilation, microvascular leakage and tracheal mucus secretion while the NK2selective antagonist, SR-48698, had antibronchoconstrictive effects.5~7) Furthermore, released neurokinins are thought to play a major role in the ongoing inflammatory response of "sensitized" sensory neurons.8) Molecules with dual NKXand NK2 antagonist activity could therefore have potentially enhanced anti-inflammatory activity.
During our search for novel neurokinin receptor 983 inhibitors, we have isolated a series of nine novel polyhydroxy-isoprenoids from a fungal fermentation broth with dual NKXand NK2antagonist-like activity. The fungus producing these isoprenoids was identified to be an Acremonium sp.
In this report, we describe fermentation of the producing fungal culture, the isolation, physico-chemical properties, structure elucidation and biological activity of these novel neurokinin receptor inhibitors.
Materials and Methods

Microorganisms
The producing microorganism was isolated from a soil sample (rhizosphere of plant roots) collected in an acid mine drainage area located in the Forward Township of Pennsylvania. The fungus producing these neurokinin inhibitors was found to belong to Acremonium sp. based on preliminary taxonomic evaluation. The strain has been deposited in Schering culture collection with accession number SCF 1559.
Fermentation Conditions
Fermentation studies were carried out in shake flasks. Stock cultures were maintained as frozen whole broths at -80°C in a final concentration of 10%glycerol. The inoculum medium contained (g/liter) Proteus Peptone 5, were monitored by NKXand NK2assays and the active fractions were combined, acetonitrile removedand the solution freeze dried to yield 0.27 g of enriched complex.
The active compounds were separated on a preparative Deltapak C-18 column eluting with an acetonitrile: water gradient. The HPLC profile of the enriched complex is shown in Figure 2 . The acetonitrile was removed from the individual peak eluates under vacuum and the remaining aqueoussolutions yielded on freeze drying 50, 10, 12, 5, 50, 0.2, 10, 0.2 and 15mgsof1, 2, 3, 4, 5, 6, 7, 8 and 9 terized only by mass spectrum ( Table 1 ). All were isolated as amorphous white powders. These compoundsshowed only end absorption in UVspectrum. The identity of sugar residue was determined by acid hydrolysis, by stirring overnight at room temperature with 6 n HC1and subsequent TLCanalysis of the hydrolysis products.9)
Receptor Binding Assays
The humanNKXand NK2receptors were expressed in CHOcells and plasma membraneswere prepared as described .10) The NKt receptor binding assay was performed by incubating [prolyl-3,4 -3H]-substance P
(1 nM at 40 Ci/mmole, Amersham International) for 40 minutes at 25°C with 10jag of CHOcell membranes expressing the humanNKXreceptor. The assay volume was 0.2ml and the buffer (pH 7.5) contained Tris-HCl (0.05 m), MgCl2 (1 mM), MnCl2 (1 him) and bovine serum albumin (1 mg/ml). The bound ligand was isolated on GFB filters (Wallac) using a Tomteká" Mach III harvester and chilled (4°C) wash buffer containing 0.05 m Tris-HCl, pH 7.5. The filter mats were impregnated with scintillant (Meltilexá", Wallac) and bound radioactivity quantitated in a Betaplateá" (Wallac) counter. Nonspecific binding was determined with a 1000 fold excess of substance P (Peninsula). The inhibitory concentration for 50% inhibition (IC50) was determined graphically from dose response curves over a concentration range of0.3 to 200jum.
The NK2 receptor binding assay was performed in an analgous manner to that described above with use of [4,5- 
3H-LEU9]-neurokinin
A]-NKA (l nM at 80Ci/ mole, Zenica) and CHOcell membranes expressing the human NK2receptor. Non-specific binding was determined with a 1000 fold excess of NKA(Peninsula).
Results
Production of the neurokinin inhibitors in the fermentation was monitored using ethyl acetate extracts of the aliquots obtained at different times during fermentation process. The production of neurokinin inhibitors in the fermentation peaked at 120 hours.
The ethyl acetate extract provided nine related isoprenoids. These compoundswere similar in nature and were extracted into ethyl acetate and further purified and separated by using reverse phase chromatography.
Structure Determination
These compoundswere low melting white waxysolids, soluble in methanol, chloroform, ethyl acetate but insoluble in water. Thosecontaining sugar were more polar than others based on HPLCmobility. SCH 60059 (1) a major component, in Cs+ ion liquid secondary ionization mass spectrum (SI-MS) (Table 1) , displayed an intense sodiated ion at m/z 939 (M+Na)+ and on addition of potassium salt gave (M+K)+ion at m/z 955 revealing the molecular weight to be 916. Peak matching measurements using high resolution mass measurementsshowed the elemental composition to be C5 1H96O13 suggesting four degrees of unsaturation. The IR spectrum displayed peaks at 3386, 2944, 1462, 1376, 1075, 755cm"1 and the 13C NMRspectrum measured in DMSO-J6 at 100.5 MHz, revealed the presence of 51 carbon atoms (Table 2 ) and 13C NMRAPT experiment showed ten methyls, twenty-one C-methylenes, two O-methylenes, six sp3 methines OCH-O, including anomeric carbon), three sp2 methines(=CH-), six sp3 quaternary carbons (;CC ) and three sp2 quaternary carbons (=CC) in the molecule. The six carbon signals in the sp2 region of the 13C NMRsuggested the presence of three double bonds and the methine signal at 98.61 ppm The absolute stereochemistry of the glucose was not determined.1" The mass spectrum (Table 1 ) of SCH60065 (2) established the molecular weight to be 900 and the elemental composition to be C51H96O12, suggesting a structure with one less oxygen than SCH60059 (1) . The 13CNMR spectrum however showedonly five oxygenated methines and hydrolysis confirmedthe presence of glucose. The 2D(1H-1H) NMR spectrum revealed the presence of fragments as shown Figure 3b . Thus 2 must be a C-10 deoxygenated analog of 1. The molecular weight of SCH64879 (3), was estabf Limited sample availability. from that of C-10 in 1. These carbon signal shifts and consideration of degree of unsaturation in the molecule suggested that they must be linked together to form a ring. The ring was established as an epoxide using HMBC experiments and assigned the structure as 3. SCH 60061 (4) showed molecular weight 738 and the elemental composition C45H87O7 ( Table  1 ). The XH NMRand 13C NMRshowed the presence of three double bonds but no sugar. The composition of this compound was C6H10O5 less than SCH 60065 (2) . The 2D (1H-1H) NMRspectrum revealed the fragments as shown in Figure 3b . The presence of only a two proton doublet at 3 4.12 due to C-l hydroxymethyl and absence oxygenated sp3 methines suggested that compounds must be an aglycone of 2.
Themolecular weight and the elemental composition of SCH 60063 (5) was established using mass spectral data (Table 1) to be 882 and C51H94O11 respectively. The XH NMRand 13C NMRof 5 showed presence of four double bonds. The 2D (1H-1H) NMR spectrum revealed the presence of fragments as shown Figure 3c . The composition of this compoundhad one H2Oless than that of 2, suggesting an additional elimination of water molecule from one of the tertiary carbon atoms. The position of this double bond was established by 2D (1H-1H) correlation studies as shown in 5. The Cs+ ion liquid secondary ionization mass spectrum (SI-MS) of SCH 60057 (7) displayed an intense molecular ion at m/z 721 (M+H)+, sodiated ion at m/z 743 (M+Na)+ and on addition of potassium salt gave an ion at m/z 759 (M+K)+ revealing the molecular weight 720. High resolution mass measurements showed the elemental composition to be C45H85O6. The XH NMRand 13C NMRshowed the presence offour double bonds but no sugar. The 2D (1H-1H) NMRspectrum revealed the presence of fragments as shown Figure 3c .
This compound has C6H10O5 less than SCH 60063 revealing it to be an aglycone of SCH 60063 (5).
Compound9 was significantly different compared to others. Its mass spectrum (SI-MS) displayed an intense molecular ion at m/z 1253 (M+H)+, revealing the molecular weight 1252 (Table 1) NKXand NK2 receptor binding activity:
The IC50 values for compounds 1~5, 7 and 9 in NKX and NK2 binding assay are shown in Table 3 . Compounds 1, 4 and 9 showed an IC50 of3jum in the NKX assay and ll jUMto 14/^m in the NK2 assay. Compound 2 was least active in both the assays with IC50's of 1fiM and 34{iM in the NKXand NK2assay respectively. IR spectra were determined on a Nicolet FTIR model 10-MXinstrument. Ultraviolet spectra were obtained by using a Hewlett Packard '8450 AVUV-vis spectrophotometer equipped with HP-9872B plotter. All Cs+ ion liquid secondary ion mass spectra (SI-MS) and high resolution mass measurements were obtained on a VG-ZAB-SEmass spectrometer using a glycerol-thioglycerol or m-nitrobenzyl alcohol matrix with the sample dissolved in dimethyl sulfoxide. NMR spectra were measured on Varian instruments, XL-300 operating at 300 and 75MHz, XL-400 operating at 400 and 100.5
MHzfor XH and 13C NMRrespectively. XH and 13C NMR, spectra were recorded relative to TMSas an internal standard. COSYspectra were measured on a Varian XL-400 instrument. 
